Historical Stories

Tumor banks have played pivotal roles in the development of diagnostic tools and therapeutic reagents, including Her-2/neu (amplified in breast cancers), prostate specific antigen (PSA test), CA125 antigen test for ovarian cancers, Herceptin (antibody therapy targeted to Her-2/neu in treatment of breast cancers) and Rituximab (monoclonal antibody to CD20) for treatment of B cell malignancies.

Find out more about our history

Did you know?

An estimated 153,100  new cases of cancer will occur in Canada in 2006.

* On average, 1,354 Canadians will die of cancer every week.
- Canadian Cancer Statistics, 2006

Based on current incidence rates, 38% of Canadian women will develop cancer during their lifetimes. Among men, 44% will develop cancer during their lifetimes.
- Canadian Cancer Statistics, 2006

How do I donate? There are many ways...

Donating tumor tissue and blood to the CBCF Tumor Bank

A promising area of cancer research is the identification and characterization of biomarkers that can predict the response of cancer...

Click here to read more
Donate to CBCF-Prairies/NWT

For Researchers